Prof. Farid Menaa is an inter- and multi-disciplinary experienced professional with worldwide reputation. Besides, he holds a MBA in Entrepreneurship. During his ongoing career he has mainly contributed to the identification and the characterization genetic biomarkers of diseases, as well to the development of pharmaceutical theranostic solutions. He has a solid background and experiences in academic, governmental and industrial environments, He is a member of several prestigious organizations and sits in numerous editorial boards of reputed journals. He has authored more than 200 articles, reviewed more than 1000 articles for the medical and scientific communities, and has participated to over 600 scientific international events where he sometimes acts as chairman and/or co-organizer. Dr. Menaa is a co-pioneer of CFS, a spectroscopy-based technology with unique features and large applicabilities in sciences, technologies, and innovations. Dr. Menaa is currently an international health expert and consultant specialist. He is the founder and CEO of MENAA group (Medicine Engineering Nanotechnology in Asia and Arabia) promoting advising and development in R&D&I in the Asian & Arabic regions of the globe.